NCT03600064View on ClinicalTrials.gov

Misoprostol for Cervical Ripening Before Copper Intrauterine Device Removal

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

July 1, 2020

Study Completion Date

September 1, 2020

Conditions
Intrauterine Device
Interventions
DRUG

Misoprostol

the women will be received two tablets of misoprostol 400 mcg vaginally before IUD removal (Misotac®; Sigma Pharma, SAE, Egypt).

Trial Locations (1)

71111

Women Health Hospital - Assiut university, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03600064 - Misoprostol for Cervical Ripening Before Copper Intrauterine Device Removal | Biotech Hunter | Biotech Hunter